4/16/2021 1:10:29 AM
Genentech Report New Data For Ocrevus Reinforce Significant Benefit On Slowing Disease Progression In RRMS And PPMS
4/15/2021 1:06:39 AM
Roche Announces New 2-yr Data From Part 2 Of FIREFISH, A Phase 2/3 Global Study Evaluating Evrysdi
4/13/2021 1:04:38 AM
Roche Says FDA Approved Supplemental Biologics License Application For Xolair
4/8/2021 1:03:50 AM
Genentech To Present New Data For Approved And Investigational Medicines For Treatment Of Neurological Disorders
4/7/2021 1:11:48 AM
Roche Launches Elecsys Anti-p53 Immunoassay To Aid Diagnosis Of Various Cancer Types
4/6/2021 7:22:35 AM
Roche Diagnostics Announces Approval Of New Elecsys Anti-SARS-CoV-2-S Test Under Health Canada's Interim Order
3/31/2021 1:28:52 AM
Roche Launches Elecsys Epstein-Barr Virus Immunoassay Panel To Improve EBV Infection Staging
3/23/2021 2:06:48 AM
Roche Unveils Eight New Configurations For Cobas Pro Integrated Solutions